References
- Valverde I, Villanueva ML. Heterogeneity of plasma immunoreactive glucagon. Metabolism 1976: 25 (Suppl 1): 1393–5
- Sasaki H, Rubalcava B, Baetens D, et al. Identification of glucagon in the gastrointestinal tract. J Clin Invest 1975: 56: 135–45
- Alberti KG, Nattrass M. The physiological function of glucagon. (Editorial) Eur J Clin Invest 1977: 7: 151–4
- Sutherland EW, Robison GA, Butcher RW. Some aspects of the biological role of adenosine 3′5′-monophosphate (cyclic AMP). Circulation 1968: 3: 279–306
- Unger RH. Alpha-and beta-cell interrelationships in health and disease. Metabolism 1974: 23: 581–93
- Gerich JE, Schneider V. Dippe SE, et al. Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Me tab 1974; 38: 77–82
- Gossain VV. Matute ML. Kalkhoff RK. Relative influence of obesity and diabetes on plasma alpha-cell glucagon. J Clin Endocrinol Metab 1974: 38: 238–43
- Böttger I, Dobbs R, Faloona GR, et al. The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity. J Clin Invest 1973: 52: 2532–41
- Marliss EB, Aoki TT, Unger RH, et al. Glucagon levels and metabolic effects in fasting man. J Clin Invest 1970: 49: 2256–70
- Felig P. Wahren J, Hendler R, et al. Plasma glucagon levels in exercising man. N Engl J Med 1972: 287: 184–5
- Iversen J. Inhibition of pancreatic glucagon release by somatostatin? in vitro. Scand J Clin Lab In vest 1974; 33: 125–9
- Müller WA, Faloona GR, Aguilar-Parada E, et al. Abnormal alpha-cell function in diabetes: response to carbohydrate and protein ingestion. N Engl J Med 1970; 283: 109–15
- Gerich JE. Langlois M, Noacco C, et al. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973: 182: 171–3
- Day JL, Tattersall RB. Glucagon secretion in unaffected monozygotic twins of juvenile diabetics. Metabolism 1975: 24: 145–51
- Müller WA, Faloona GR. Unger RH. The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest 1971: 50: 1992–9
- Unger RH. Role of glucagon in the pathogenesis of diabetes? the status of the controversy. Metabolism 1978; 27: 1691–1709
- Lindsey CA, Faloona GR, Unger RH. Plasma glucagon in nonketotic hyperosmolar coma. JAMA 1974: 229: 1771–3
- Gerich JE, Lorenzi M. Bier DM, et al. Prevention of human diabetic ketoacidosis by somatostatin: evidence for an essential role of glucagon. N Engl J Med 1975: 292: 985–9
- Felig P, Wahren J, Sherwin R, et al. Insulin, glucagon. and somatostatin in normal physiology and diabetes mellitus. Diabetes 1976: 25: 1091–9
- Unger RH, Orci L. Glucagon and the A cell: physiology and pathophysiology. N Engl J Med 1981: 304: 1518–24, 1575–80